BACE1 and Cognitive impairment: It was observed that BACE1 activity was significantly associated with amyloid-beta peptide levels [94,96] and t-tau in mild cognitive impairment subgroups [31], suggesting its involvement in the pathogenesis of Alzheimer’s disease.